Table 3.
Intention-to-treat and per protocol analyses of the secondary outcomes measures
| Mean change |
Mean difference between groups | P* | ||
|---|---|---|---|---|
| Control | Intervention | |||
| HADS-D | −0.833 | −0.233 | 0.149 (−1.03, 1.33) | 0.410 |
| SF-12 | ||||
| PCS | −1.16 | −2.820 | 1.660 (−0.62, 3.94) | 0.209 |
| MCS | 0.141 | −0.352 | 0.493 (−2.70, 3.69) | 0.966 |
| Control | App users | |||
| HADS-D | −0.833 | −0.6667 | 0.583 (−0.62, 1.78) | 0.335 |
| SF-12 | ||||
| PCS | −1.160 | −4.322 | 3.163 (0.52, 5.80) | 0.042 |
| MCS | 0.141 | 1.364 | −1.223 (−4.93, 2.48) | 0.476 |
Subgroup analysis on participants in the intervention group by use of the eHealth tool. Values in parentheses are 95% confidence intervals. HADS-D, Hospital Anxiety and Depression Scale Depression; SF-12, short-form 12-item health survey; PCS, physical component summary; MCS, mental component summary.
*Mann–Whitney test.